Vivo Ventures V, Llc, Ten Percent Owner at Sagent Pharm, holds 3.63M shares in Soleno Therapeutics (Ticker: SLNO), holds 34.98K shares in Sagent Pharm (Ticker: SGNT), holds 183.77K shares in MEI Pharma (Ticker: MEIP). Most recently, Vivo Ventures V, Llc Sold ― shares of Soleno Therapeutics on Dec 03, 2019 for an estimated value of 55.13K.
What is the percentage of profitable transactions made by Vivo Ventures V, Llc?
The percentage of profitable transactions made by Vivo Ventures V, Llc is 39%.
What is the average return per transaction made by Vivo Ventures V, Llc?
The average return per transaction made by Vivo Ventures V, Llc is -14.80%.
What stocks does Vivo Ventures V, Llc hold?
Vivo Ventures V, Llc holds: SGNT, SLNO, MEIP, ALBO stocks.
What was Vivo Ventures V, Llc’s latest transaction?
Vivo Ventures V, Llc latest transaction was an Informative Sell of $55.13K.
What was Vivo Ventures V, Llc's most profitable transaction?
Vivo Ventures V, Llc’s most profitable transaction was an Informative Sell of MEIP stock on May 20, 2013. The return on the trade was 29.20%.
What is Vivo Ventures V, Llc's role in Sagent Pharm?
Vivo Ventures V, Llc's role in Sagent Pharm is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.